Author:
Chen Yan,Wang Ping,Zhang Yin,Du Xiao-Yu,Zhang Ying-Jian
Abstract
AbstractTo compare the effects of aminosalicylic acid, glucocorticoids and immunosuppressants on the expression levels of multidrug resistance genes in patients with ulcerative colitis (UC), with the aim of providing a theoretical and therapeutic basis for the diagnosis, treatment, and prevention of UC. Fresh colonic mucosal tissues or postoperative pathological biopsies from 148 UC patients were collected, and the distribution sites and morphology of P-glycoprotein (P-gp) were detected using immunohistochemical staining. RT-PCR was used to quantify the expression levels of multidrug resistance gene (MDR1) mRNA before and after the corresponding treatment, and the effects of aminosalicylic acid, glucocorticoids and immunosuppressive drugs on P-gp were compared. In addition, the effects of the three drugs on MDR1 mRNA were analyzed. Administration of 5-aminosalicylic acid (5-ASA) drugs did not correlate with MDR1 expression in UC, whereas administration of glucocorticoids and immunosuppressive drugs was positively correlated with MDR1 expression profile. The expression levels of MDR1 mRNA and its product P-gp were significantly upregulated in patients who did not respond to glucocorticoids and immunosuppressive drugs. 5-ASA had no effect on the expression levels of MDR1 and its product P-gp in patients with a confirmed diagnosis of UC. However, the use of glucocorticoids and immunosuppressants can increase the expression level of MDR1.
Funder
Scientific Research Fund of Henan Provincial Science and Technology Department
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Zaragoza-García, O., Castro-Alarcón, N., Pérez-Rubio, G. & PaolaGuzmán-Guzmán, I. DMARDs–Gut microbiota feedback: Implications in the response to therapy. Biomolecules. 10, 1479 (2020).
2. Ford, A. C. et al. Efficacy of 5-aminosalicylates in UC: Systematic review and meta-analysis. Am. J. Gastroenterol. 106(4), 601–616 (2011).
3. Guobin, H., Xianfei, W. & Guizhen, Y. Analysis of 15 cases of relief of gastrointestinal reaction caused by salazosulfpyridine in the treatment of UC. J. Gastroenterol. Hepatol. 07, 607 (2009).
4. Berends, S. E., Strik, A. S. & Löwenberg, M. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of UC. Clin. Pharmacokinet. 58(1), 15–37 (2019).
5. Helbig, G. et al. Real life data on efficacy and safety of azacitidine therapy for myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia. Pathol. Oncol. Res. 25(3), 1175–1180 (2019).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献